Stine Ulrik Mikkelsen

Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen et al. · Haematologica · 2019 · 103 citations · Full text

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis

Stine Ulrik Mikkelsen, Lasse Kjær, Mads Emil Bjørn et al. · Cancer Medicine · 2018 · 44 citations · Full text

Immunodeficiencies, Immunology, Pathology +19

Prognosis of vibration induced white finger: a follow up study.

Rolf Petersen, Mads J. Andersen, Stine Ulrik Mikkelsen et al. · Occupational and Environmental Medicine · 1995 · 39 citations · Full text

Vibrations, Good Prognosis, Medicine +10

The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention—A pilot study

Mette Munk Lauridsen, Stine Ulrik Mikkelsen, T.H. Svensson et al. · PLoS ONE · 2017 · 20 citations · Full text

Safety and Efficacy of Combination Therapy of Interferon-Alpha2 + JAK1-2 Inhibitor in the Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Preliminary Results from the Danish Combi-Trial - an Open Label, Single Arm, Non-Randomized Multicenter Phase II Study

Stine Ulrik Mikkelsen, Lasse Kjær, Vibe Skov et al. · Blood · 2015 · 17 citations